ArticlePain and therapy2026
Effect of Esketamine Combined with Lidocaine on Opioid Requirements in the Elderly Undergoing Laparoscopic Colorectal Cancer Surgery: A Randomized, Double-Blind, Controlled Trial.
Article in Pain and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
introductionPostoperative pain after surgery for colorectal cancer (CRC) is prone to multiple complications, and opioids are accompanied by significant side effects. There is still unclear evidence regarding the combination of esketamine and lidocaine. This trial was designed to get into the bottom of the synergistic effect of esketamine and lidocaine on reducing opioid requirements in the elderly undergoing CRC surgery.
methodsThis study enrolled 151 patients to establish the control group (group C, n = 50), the esketamine group (group S, n = 50), and the esketamine + lidocaine group (group SL, n = 51). The primary endpoint was the total sufentanil consumption within 24 h post-surgery.
resultsDuring the first 24 h postoperatively, compared with group C {103.22 μg (103.22 morphine milligram equivalents [MME]), 98.30-108.25 μg}, both group S (100.29 μg [100.29 MME], 99.60-104.43 μg) and group SL (95.13 μg [95.13 MME], 95.20-100.40 μg) had reduced dosage of sufentanil (mean, interquartile range [IQR]) (P < 0.001); while at the remaining time points, groups S/SL were also lower than group C (P < 0.05). The numeric rating scale (NRS) pain scores in the two postoperative days were lower in groups S/SL than in group C, even lower in group SL than group S (P < 0.001). The intraoperative heart rate and mean blood pressure were more likely to be elevated in group S than in group C, while it was lower in group SL than in group S (P < 0.05). Group SL had an accelerated recovery of gastrointestinal function and higher subjective postoperative recovery quality scores on the third and seventh postoperative days than group C (P < 0.05), as well as lower rate of postoperative nausea and vomiting (P = 0.022).
conclusionsEsketamine combined with lidocaine may reduce opioid consumption, improve postoperative analgesia, and better maintain hemodynamic stability during CRC surgery in elderly patients. TRIAL REGISTRATION INFORMATION: Chinese Clinical Trial Registry (registration no. ChiCTR2300078997; registration date: 22 December 2023).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.